ImageneBio, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | -178.9% | – | – | – | – | – | |
| – | -42.4% | +23.5% | +81.3% | +38.1% | +35.8% | -52.0% | -33.1% | |
| – | +272.3% | +53.7% | +188.1% | +45.4% | +1.4% | -30.6% | +190.7% | |
| – | +109,301.7% | -112.2% | – | – | – | – | – | |
| – | +3.6% | +142.4% | +129.8% | -18.7% | -71.1% | -100.0% | – | |
| – | -102.9% | – | -160.2% | +5,541.1% | – | -154.4% | -83.3% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +100.0% | |
| – | – | +612.1% | +13.4% | -99.2% | +6,838.8% | -90.9% | +1,861.6% | |
| – | – | +27.1% | -14.2% | -347.1% | – | -234.9% | – | |
| – | – | -181.1% | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.